Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence
A cancer stem cell (CSC) is an immortal cell that is capable of self-renewal, continuous proliferation, differentiation into various cancer cell lineages, metastatic dissemination, tumorigenesis, maintaining tumor heterogeneity, and resistance to conventional treatments. Targeted therapies have made...
Saved in:
| Main Authors: | Divya Vishambhar Kumbhakar, Lucky Thakkar, Chetana Akhand, Shehna Sharaf, Geeta K. Vemuganti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1499283/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regenerative properties of bone marrow mesenchymal stem cell derived exosomes in rotator cuff tears
by: Junjie Chen, et al.
Published: (2025-01-01) -
Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons
by: Minhye Kim, et al.
Published: (2024-11-01) -
Harnessing exosomes for targeted drug delivery systems to combat brain cancer
by: Abdullah E. Basyoni, et al.
Published: (2025-04-01) -
Harnessing Exosomes: A Brief Overview of Nature’s Nanocarriers and a Glimpse into Their Implications in Pituitary Neuroendocrine Tumors (PitNETs)
by: Ligia Gabriela Tataranu
Published: (2025-04-01) -
Effect of mesenchymal stem cell-derived exosomes on the inflammatory response after stroke
by: Ozal Beylerli, et al.
Published: (2024-10-01)